Last updated: July 11, 2026

Application No. 18/705,711

Untitled Application

Unknown

Filed

1600

Priority

Oct 29, 2021 — IN 202121049524 +1 more

Examiner

WILLIS, DOUGLAS M

Art Unit

1629

Tech Center

KASHIV BIOSCIENCES, LLC

Assignee

Kashiv Biosciences LLC

OA Round

1 (Non-Final)

Interview Optional

— +19.6% interview lift. Examiner has a relatively high allowance rate (82%); +19.6% interview lift. A written response may suffice.

Based on 1799 resolved cases, 2023–2026

Examiner Intelligence

WILLIS, DOUGLAS M View full profile →

Grants 82% — above average

Career Allowance Rate

1483 granted / 1799 resolved

+22.4% vs TC avg

Strong +20% interview lift

Without

With

+19.6%

Interview Lift

resolved cases with interview

Fast prosecutor

1y 10m

Avg Prosecution

77 currently pending

Career history

1832

Total Applications

across all art units

Statute-Specific Performance

§101

0.1%

-39.9% vs TC avg

§103

11.3%

-28.7% vs TC avg

§102

16.3%

-23.7% vs TC avg

§112

42.0%

+2.0% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1799 resolved cases

Prosecution Timeline

1600

Application Filed

Precedent Cases

Applications granted by this same examiner with similar technology

17/906,600

Patent 12673046

SUBSTITUTED TETRAZOLES AS ACSS2 INHIBITORS

3y 9m to grant Granted Jul 07, 2026

17/921,203

Patent 12673946

PYRIMIDIN-4(3H)-ONE DERIVATIVES AS TRPV4 ANTAGONISTS

3y 8m to grant Granted Jul 07, 2026

18/197,979

Patent 12673953

PROCESS FOR PREPARING AN AMORPHOUS FORM OF 2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXYPHENYL)PYRAZOLO[3,4-d]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILE

3y 1m to grant Granted Jul 07, 2026

17/510,815

Patent 12662484

SUBSTITUTED PIPERIDINES AS TYROSINE KINASE INHIBITORS

4y 8m to grant Granted Jun 23, 2026

17/999,101

Patent 12662485

GUT-TARGETED PHOSPHODIESTERASE INHIBITORS

3y 7m to grant Granted Jun 23, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

82%

Grant Probability

99%

With Interview (+19.6%)

1y 10m

Median Time to Grant

Low

PTA Risk

Based on 1799 resolved cases by this examiner. Grant probability derived from career allowance rate.